LAG3 anticorps (Internal Region)

N° du produit ABIN6391370

L’anticorps Chèvre Polyclonal anti-LAG3 a été validé pour WB et ELISA. Il convient pour détecter LAG3 dans des échantillons de Humain.

Aperçu rapide pour LAG3 anticorps (Internal Region) (ABIN6391370)

Antigène: LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

Reactivité: Humain

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp LAG3 est non-conjugé

Application: Western Blotting (WB), ELISA

Classe de qualité: Verified

Détail du produit anti-LAG3 anticorps

Épitope: Internal Region

Fonction: LAG3 / CD223

Séquence: EDVSQAQAGT YTCH

Specificité: This antibody is expected to recognize the extra-cellular domain.

Réactivité croisée: Humain

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Isotype: IgG

Information d'application

Indications d'application:

Western Blot: Approx 55 kDa band observed in Human Lymph Node and Tonsil lysates (calculated MW of 57.4 kDa according to NP_002277.4). Recommended concentration: 0.3-1 μg/mL.

Peptide ELISA: antibody detection limit dilution 1:2000.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Minimize freezing and thawing.

Stock: -20 °C

Stockage commentaire: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Détails sur LAG3

Antigène: LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

Autre désignation: LAG3

Sujet: LAG3, lymphocyte activating 3, CD223, lymphocyte-activation gene 3

ID gène: 3902

NCBI Accession: NP_002277

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints